QUOTE AND NEWS
TheStreet.com  Aug 28  Comment 
NEW YORK (The Deal) -- Despite months of pushback from the target, Mylan announced on Friday that its shareholders have approved the company's proposed acquisition of Perrigo for $31.2 billion. In Friday's statement, Hertfordshire,...
newratings.com  Aug 28  Comment 
LONDON (dpa-AFX) - Perrigo Company plc (PRGO) announced that it has completed the acquisition of leading OTC brands from GSK in an all cash transaction valued at 200 million euros. Perrigo noted that it continues to expect the acquisition to be...
Market Intelligence Center  Aug 28  Comment 
A covered call identified by MarketIntelligececenter.com's patented algorithms on Perrigo (PRGO) could yield about 6.08% (26.44% annualized, for comparison purposes only) in 84 days. Pair a long position in the stock with the Nov. '15 $185.00 call...
newratings.com  Aug 28  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...
FiercePharma  Aug 26  Comment 
Perrigo may be embroiled in a takeover fight with pursuer Mylan, but that hasn't stopped it from pursuing tie-ups of its own--even $1 billion-plus buys.
newratings.com  Aug 26  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...
newratings.com  Aug 26  Comment 
CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) tody commented on the statements made by Perrigo Company plc (PRGO) in relation to Mylan's offer to acquire Perrigo. Mylan also noted that the Irish Takeover Panel has issued a formal statement...




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki